On the other hand, findings suggest that high c-MET activity, reflected in elevated HGF levels, may contribute to an immunosuppressive tumor microenvironment that hampers the efficacy of PD-1/PD-L1 blockade. The gene discussed is CD274; the disease is neoplasm.